| 000 | 01825 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514061746.0 | ||
| 264 | 0 | _c20030923 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1703795 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchulman, K A | |
| 245 | 0 | 0 |
_aEconomic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cFeb 2003 |
||
| 300 |
_a205-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xeconomics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEconomics, Hospital |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aStem Cell Transplantation _xeconomics |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aStadtmauer, E A | |
| 700 | 1 | _aReed, S D | |
| 700 | 1 | _aGlick, H A | |
| 700 | 1 | _aGoldstein, L J | |
| 700 | 1 | _aPines, J M | |
| 700 | 1 | _aJackman, J A | |
| 700 | 1 | _aSuzuki, S | |
| 700 | 1 | _aStyler, M J | |
| 700 | 1 | _aCrilley, P A | |
| 700 | 1 | _aKlumpp, T R | |
| 700 | 1 | _aMangan, K F | |
| 700 | 1 | _aGlick, J H | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 31 _gno. 3 _gp. 205-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1703795 _zAvailable from publisher's website |
| 999 |
_c12417039 _d12417039 |
||